JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.4299?guestAccessKey=3faf8cc0-3718-4b07-a5eb-fc81fa410537&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090822
About The Study: When Omicron was the dominant variant during the early months of 2022 from January to April, COVID-19-associated hospitalization rates were 10.5 times higher in unvaccinated adults and 2.5 times higher in vaccinated adults with no booster dose compared with those who had received a booster dose. Results of the study suggest that clinicians and public health practitioners should continue to promote vaccination with all recommended doses for eligible persons.
Authors: Fiona Havers, M.D., M.H.S., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.